These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma. Rohila D; Park IH; Pham TV; Jones R; Tapia E; Liu KX; Tamayo P; Yu A; Sharabi AB; Joshi S Front Immunol; 2023; 14():1148317. PubMed ID: 37350973 [TBL] [Abstract][Full Text] [Related]
11. Identification of hub genes and their correlation with infiltration of immune cells in Chen J; Sun M; Chen C; Jiang B; Fang Y Front Immunol; 2022; 13():1016683. PubMed ID: 36311753 [TBL] [Abstract][Full Text] [Related]
12. De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482 [TBL] [Abstract][Full Text] [Related]
13. MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma. Guan J; Li M; Wang Y; Zhang Y; Que Y; Lu S; Wang J; Zhu J; Huang J; Zhen Z; Sun F; Song M; Zhang Y Cell Death Dis; 2024 Feb; 15(2):124. PubMed ID: 38336749 [TBL] [Abstract][Full Text] [Related]
14. Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092 [TBL] [Abstract][Full Text] [Related]
15. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells. Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic Dysregulation in Epp S; Chuah SM; Halasz M Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069407 [TBL] [Abstract][Full Text] [Related]
18. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma. Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452 [TBL] [Abstract][Full Text] [Related]
19. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620 [TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma. Weng Z; Lin J; He J; Gao L; Lin S; Tsang LL; Zhang H; He X; Wang G; Yang X; Zhou H; Zhao H; Li G; Zou L; Jiang X Neuro Oncol; 2022 Jun; 24(6):872-885. PubMed ID: 34655293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]